19G FNB Needle vs 22G FNB Needle for EUS-Guided Liver Biopsy

Phase

N/A

Condition

N/A

Treatment

22-gauge

19-gauge

Clinical Study ID

NCT06643520

EUS-LB

Ages 18-80
All Genders

Study Summary

EUS-guided liver biopsy (EUS-LB) is increasingly used to diagnose patients with liver disease, especially in anxious patients who need sedation. There is an ongoing debate about the optimal needle size for EUS-LB. Some clinicians prefer a thinner 22-gauge biopsy needle because they presume it to be safer, and some studies show that their performance is the same as a thicker 19-gauge needle. However, some other studies show that the adequacy and diagnostic accuracy of a 19-gauge needle is better, and the rates of adverse events are the same. In this study, we aimed to compare the adequacy and diagnostic accuracy of samples obtained by the same endoscopist from the same liver lobe during the same session.

Eligibility Criteria

Inclusion

Inclusion Criteria:

All patients with unexplained elevation of liver enzymes and suspected hepaticparanchymal disease

Exclusion

Exclusion Criteria:

Patients who had malignancy
Patients who have decompensated cirrhosis
Presence of ascites
Patients with coagulopathy (platelets < 50.000 μ/ mL and INR > 1.5)
The use of anticoagulant agents
Pregnancy
Unable to provide written informed consent

Study Design